Page last updated: 2024-08-21

isoxazoles and Lymphoma, Mantle-Cell

isoxazoles has been researched along with Lymphoma, Mantle-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bararia, D; Bird, L; Christie, AL; Christodoulou, A; Haebe, S; Jacobson, C; Kopp, N; Layer, JV; Redd, RA; Rodig, SJ; Saur, A; Tivey, T; Tschuri, S; van Bodegom, D; Weigert, O; Weinstock, DM; Zapf, S; Zimber-Strobl, U	1

Other Studies

1 other study(ies) available for isoxazoles and Lymphoma, Mantle-Cell

Article	Year
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma. Blood, 2016, 11-24, Volume: 128, Issue:21 Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Amino Acid Substitution; Animals; Cell Line, Tumor; Drug Resistance, Neoplasm; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lymphoma, Mantle-Cell; Mice; Mutation, Missense; Piperidines; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Resorcinols; Xenograft Model Antitumor Assays	2016

Article

Year

HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma.

Blood, 2016, 11-24, Volume: 128, Issue:21

Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Amino Acid Substitution; Animals; Cell Line, Tumor; Drug Resistance, Neoplasm; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lymphoma, Mantle-Cell; Mice; Mutation, Missense; Piperidines; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Resorcinols; Xenograft Model Antitumor Assays

2016